Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Cash & Current Investments (2016 - 2025)

Bio-Techne (TECH) has 17 years of Cash & Current Investments data on record, last reported at $172.9 million in Q4 2025.

  • For Q4 2025, Cash & Current Investments fell 4.37% year-over-year to $172.9 million; the TTM value through Dec 2025 reached $172.9 million, down 4.37%, while the annual FY2025 figure was $162.2 million, 6.1% up from the prior year.
  • Cash & Current Investments reached $172.9 million in Q4 2025 per TECH's latest filing, up from $145.0 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $279.0 million in Q4 2021 and bottomed at $130.1 million in Q4 2023.
  • Average Cash & Current Investments over 5 years is $192.2 million, with a median of $187.5 million recorded in 2024.
  • Peak YoY movement for Cash & Current Investments: surged 99.23% in 2021, then tumbled 33.86% in 2023.
  • A 5-year view of Cash & Current Investments shows it stood at $279.0 million in 2021, then fell by 29.47% to $196.8 million in 2022, then crashed by 33.86% to $130.1 million in 2023, then surged by 38.92% to $180.8 million in 2024, then dropped by 4.37% to $172.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Current Investments were $172.9 million in Q4 2025, $145.0 million in Q3 2025, and $162.2 million in Q2 2025.